PyInvesting

Market research

ALEMBICLTD.NSE Alembic Limited

NSE INR Real Estate

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
24B
P/E ratio
7.42
Analyst target
725
Dividend yield
0.0%
Beta
0.64

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Alembic Limited is currently in a long term uptrend where the price is trading 17.9% above its 200 day moving average.

From a valuation standpoint, the stock is 1048.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 55.0.

Alembic Limited's total revenue rose by 13.5% to $145M since the same quarter in the previous year.

Its net income has increased by 25.8% to $856M since the same quarter in the previous year.

Finally, its free cash flow grew by 176.6% to $27M since the same quarter in the previous year.

Based on the above factors, Alembic Limited gets an overall score of 4/5.